The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

The Implications of Recent Datasets for the C...

Up next

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer. CME information and select publications here. 

Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer

Dr Floor J Backes from The James Cancer Hospital and Solove Research Institute in Columbus, Ohio, Dr Matthew A Powell from the Washington University School of Medicine in St Louis, Missouri, and Dr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, Calif ...  Show more